
IM PGY-3 @TigmerSA_IntMed| Chief Resident | Former @mayoclinic Research Fellow and @Mayomrfa Florida Chair | Aspiring Cardiologist 🫀| Karaoke 👸
San Antonio, TX
Joined September 2012
- Tweets1.7K
- Following3.3K
- Followers1.5K
- Likes5.2K
I am thrilled to join the women's cohort of the ACC IM Cardiology Program, @ACCinTouch! Hearing about these inspiring journeys reinforces that every person has a unique path, and I am eager to discover mine in Cardiology. 🫀 @TigmerSA_IntMed @LatinasInMed
2
31
1,883
Ginna (Geovanna) Yepez, MD 🇪🇨 retweeted
The International Symposium of Critical Care in Cancer Patients returns to @MDAndersonNews, Nov 4–6.
🔹 Oncologic critical care
🔹 POCUS workshop
🔹 In-person + virtual
A great opportunity to learn and connect.
🔗 mdanderson.cloud-cme.com/cou…
@ONCCCRNET #OncCrit #CriticalCare
Ginna (Geovanna) Yepez, MD 🇪🇨 retweeted
What an incredible session hosted by @ACCinTouch #CardioOb in collab with #accfit. Loved sharing my experiences and truly learned so much from the speakers! Absolute super💫 FITs, ECs and PDs! Can’t wait to join the council and continue learning as I enter early career!
Ginna (Geovanna) Yepez, MD 🇪🇨 retweeted
LIVE IN ONE HOUR! Grand Rounds conference featuring William A. Zoghbi, MD, presenting “The Exciting Future of Cardiovascular Imaging.”
Watch LIVE: bit.ly/GR091726
#DeBakeyCVEdu #HoustonMethodist #GrandRounds
Ginna (Geovanna) Yepez, MD 🇪🇨 retweeted
Pneumococcal bacteremia with encephalopathy should prompt early TTE and cerebrospinal fluid evaluation to identify Austrian syndrome and guide antimicrobial and source control decisions.
Get the details in #JACCCaseReports: jacc.org/doi/10.1016/j.jacca… #ACCLATAM @IvanRafaelMD
Ginna (Geovanna) Yepez, MD 🇪🇨 retweeted
The Department of Internal Medicine at UTMB is hiring a Vice Chair for Education. We train most of the institution's internal medicine residents, fellows, and medical students. I want someone who wants to rebuild how we do it.
I’m excited to share that we are looking for a postdoctoral researcher to join my lab at Yale.
If you, or someone you know, might be interested, please feel free to reach out or share this post.
postdocs.yale.edu/posts/2026…
Ginna (Geovanna) Yepez, MD 🇪🇨 retweeted
I’m excited to share that we are looking for an ambitious and talented postdoctoral fellow to join my lab working on cardiovascular and metabolism research. We are located at Weill Cornell medical school in New York City. postdocs.weill.cornell.edu/o…
Ginna (Geovanna) Yepez, MD 🇪🇨 retweeted
Women’s CV risk evolves across the life course.
A life-stage prevention approach can help identify risk earlier, address inequities, and move from episodic treatment toward coordinated, lifelong prevention and equitable cardiovascular outcomes.
jacc.org/doi/10.1016/j.jacad…
Ginna (Geovanna) Yepez, MD 🇪🇨 retweeted
We are looking for a Research Scientist to join our Cardiac Imaging Research Lab. See link for more details. uva.wd1.myworkdayjobs.com/en…
🩺 Join us for the TIGMER San Antonio Internal Medicine Residency Virtual Open House!
📅 Sept 10 | 7 PM CT
💻 Microsoft Teams
Meet our residents, learn about our program & ask questions!
No visa sponsorship.
Please share!
#Match2027 #InternalMedicine
230
Ginna (Geovanna) Yepez, MD 🇪🇨 retweeted
🫀 Mi primer post educativo.
Con la ayuda de AI, pude generar el arte de mis prompts sobre los ensayos, a mi entender, más importantes en el ESC Congress 2026:
✅ 8 positivos: digitoxin en ICrEF, PADN en HP, NOAC post-TAVI, baxdrostat en HTA resistente…
⚖️ 7 mixtos
❌ 3 negativos (que también importan 💡)
Desliza y dime qué te parece 🙌 Si les resulta útil, ¡repito con los próximos congresos! #ESC2026 #Cardiología #MedEd
🤖 Made with AI
Ginna (Geovanna) Yepez, MD 🇪🇨 retweeted
🫀 #HHeFT at #ESCCongress
Does hydralazine–isosorbide dinitrate improve outcomes in a broader contemporary HFrEF population?
🫀592 patients randomized to H-ISDN vs placebo
🫀Primary endpoint:
➡️ 8.6 vs 9.3 events/100 patient-years
HR 0.90 (95% CI 0.67–1.21) ❌
🫀All-cause mortality:
➡️ 19.4% vs 24.2%
HR 0.72 (0.51–1.02)❌
❌High treatment discontinuation was an important limitation of the trial
🌟H-ISDN did not significantly improve the primary outcome in contemporary HFrEF
#HFrEF #HeartFailure #CardioTwitter
Ginna (Geovanna) Yepez, MD 🇪🇨 retweeted
A major step forward for women at #ESCCongress 🫀
The new 5th Universal Definition of MI explicitly requires sex-specific 99th-percentile troponin thresholds recognizing that using the same cutoff in women and men can systematically underdiagnose myocardial injury in women
It also recognizes SCAD, coronary vasospasm & embolism as causes of primary MI—mechanisms especially important in women.
Women’s heart attacks don’t always look like men’s. Our definitions finally reflect that. We wanted to enforce this in the Cheat Pain guidelines but we didn’t have enough data in the US at that time. Glad this has changed!
#CardioTwitter #WomensHeartHealth #MyocardialInfarction
🤖 Made with AI
Ginna (Geovanna) Yepez, MD 🇪🇨 retweeted
🚨 Deadline Extended! The ACC Young Scholars Program is for high school students interested in a career in cardiology, science, or health care.
Learn more about the program & share this opportunity w/ your network. ⌛ Applications now due Sept. 11! ➡️ bit.ly/4yR3JVk
Ginna (Geovanna) Yepez, MD 🇪🇨 retweeted
Managing #cardiorenal syndrome in #ADHF remains a major clinical challenge, particularly when persistent congestion or diuretic resistance limits effective decongestion.
A new @ESCHeartFailure review proposes a mechanistic framework for device-based therapies:
📍Pullers: ⬇️ venous or lymphatic congestion
📍Pushers: ⬆️ arterial/renal perfusion
📍Removers: direct sodium and/or fluid removal
However⚠️:
📍Optimized pharmacological decongestion remains effective for most patients
📍Device-based approaches are being explored as adjuncts when congestion persists despite appropriate care
📍Matching the device mechanism to the dominant cardiorenal pathophysiology may be critical
📍For most devices, current evidence remains largely early-phase & physiological
📍Randomized trials are needed to demonstrate benefit beyond optimized contemporary medical therapy
📚Read more: doi.org/10.1093/eschf/xvag19…
#HF #HeartFailure @escardio #HFA_ESC
@JeroenDauw @JanBiegus @WilfriedMullens
Ginna (Geovanna) Yepez, MD 🇪🇨 retweeted
#HOTLINE 2 is the one for #CVPrev #Cardiotwitter #ESCCongress
🫀Should healthy 70-somethings be on a #statin? #STAREE has the answer.
🫀AMUNDSEN asks why we wait weeks post-MI to hit LDL goals instead of treating NOW
🫀TRANQUILITY- IL-6: Target or No?
Prevention might be more aggressive depending on these results!
Ginna (Geovanna) Yepez, MD 🇪🇨 retweeted
⏰ Don't forget to submit your #ACCIMProgram & Pediatric Cardiology Program application no later than Monday, Aug. 24!
Learn how the program can guide your career in #cardiology 👉 bit.ly/4y2nSYc #ACCHealthEquity #TheFaceOfCardiology #cvPed
Ginna (Geovanna) Yepez, MD 🇪🇨 retweeted
Good news! We've extended the deadline for our Annual Abstract Competition to Wednesday, Aug. 26.
Submit your research, a case report or clinical project: tcacc.memberclicks.net/annua…
Ginna (Geovanna) Yepez, MD 🇪🇨 retweeted
Join us!!!
Women’s 🫀 Health: What’s New in Lipid Guidelines? We're kicking off the 2026–2027 academic year of our accredited ADVANCES series with a powerhouse panel! Join @DrMarthaGulati, Harmony Reynolds, Leslie Cho & Tamar Polonsky as they explore the new AHA Lipid Guidelines. Details⤵️
Ginna (Geovanna) Yepez, MD 🇪🇨 retweeted
🆕 Deadline: Aug. 24!
There's still time to apply to the #ACCIMProgram & Pediatric Cardiology Program. Residents advancing in their training gain access to ACC resources, fellowship application support ➕ more, like Dr. Ashley Rodgers.
🔗 bit.ly/4y2nSYc #ACCHealthEquity










































